SHLD3
gene geneOn this page
Also known as AC008560.1FLJ26957CTC-534A2.2RINN1
Summary
SHLD3 (shieldin complex subunit 3, HGNC:53826) is a protein-coding gene on chromosome 5q12.3, encoding Shieldin complex subunit 3 (Q6ZNX1). Component of the shieldin complex, which plays an important role in repair of DNA double-stranded breaks (DSBs). It is a selective cancer dependency (DepMap: 11.4% of cell lines).
Involved in negative regulation of double-strand break repair via homologous recombination; positive regulation of double-strand break repair via nonhomologous end joining; and positive regulation of isotype switching. Located in nucleolus; nucleoplasm; and site of double-strand break.
Source: NCBI Gene 112441434 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 3 total
- Cancer dependency (DepMap): dependent in 11.4% of screened cell lines
- MANE Select transcript:
NM_001365341
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:53826 |
| Approved symbol | SHLD3 |
| Name | shieldin complex subunit 3 |
| Location | 5q12.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | AC008560.1, FLJ26957, CTC-534A2.2, RINN1 |
| Ensembl gene | ENSG00000253251 |
| Ensembl biotype | protein_coding |
| OMIM | 618030 |
| Entrez | 112441434 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000510585, ENST00000514404, ENST00000931102
RefSeq mRNA: 1 — MANE Select: NM_001365341
NM_001365341
CCDS: CCDS93722
Canonical transcript exons
ENST00000510585 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002041841 | 65625027 | 65625106 |
| ENSE00002057630 | 65629468 | 65630928 |
Expression profiles
Bgee: expression breadth ubiquitous, 185 present calls, max score 81.19.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 9.9337 / max 215.3042, expressed in 1721 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 56693 | 9.9337 | 1721 |
Top tissues by expression
240 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| monocyte | CL:0000576 | 81.19 | gold quality |
| leukocyte | CL:0000738 | 80.76 | gold quality |
| cortical plate | UBERON:0005343 | 79.10 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.03 | gold quality |
| islet of Langerhans | UBERON:0000006 | 76.84 | gold quality |
| ganglionic eminence | UBERON:0004023 | 73.68 | gold quality |
| granulocyte | CL:0000094 | 73.44 | gold quality |
| calcaneal tendon | UBERON:0003701 | 73.02 | gold quality |
| adrenal tissue | UBERON:0018303 | 72.76 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 72.67 | gold quality |
| rectum | UBERON:0001052 | 71.53 | gold quality |
| ventricular zone | UBERON:0003053 | 71.15 | gold quality |
| pancreas | UBERON:0001264 | 71.01 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 70.93 | gold quality |
| lymph node | UBERON:0000029 | 70.92 | gold quality |
| adenohypophysis | UBERON:0002196 | 70.80 | gold quality |
| bone marrow | UBERON:0002371 | 70.21 | gold quality |
| gastrocnemius | UBERON:0001388 | 70.20 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 70.18 | gold quality |
| vermiform appendix | UBERON:0001154 | 70.09 | gold quality |
| left adrenal gland | UBERON:0001234 | 69.97 | gold quality |
| muscle of leg | UBERON:0001383 | 69.92 | gold quality |
| right adrenal gland | UBERON:0001233 | 69.85 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 69.67 | gold quality |
| right lobe of liver | UBERON:0001114 | 69.62 | gold quality |
| body of pancreas | UBERON:0001150 | 69.59 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 69.55 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 69.29 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 69.09 | gold quality |
| spleen | UBERON:0002106 | 69.04 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.57 |
Regulation
Is transcription factor: no
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 11.4% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 1)
- Structural basis for shieldin complex subunit 3-mediated recruitment of the checkpoint protein REV7 during DNA double-strand break repair. (PMID:31796627)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zgc:101664 | ENSDARG00000035700 |
| mus_musculus | Shld3 | ENSMUSG00000118537 |
| rattus_norvegicus | Shld3 | ENSRNOG00000072257 |
Protein
Protein identifiers
Shieldin complex subunit 3 — Q6ZNX1 (reviewed: Q6ZNX1)
Alternative names: REV7-interacting novel NHEJ regulator 1, Shield complex subunit 3
All UniProt accessions (1): Q6ZNX1
UniProt curated annotations — full annotation on UniProt →
Function. Component of the shieldin complex, which plays an important role in repair of DNA double-stranded breaks (DSBs). During G1 and S phase of the cell cycle, the complex functions downstream of TP53BP1 to promote non-homologous end joining (NHEJ) and suppress DNA end resection. Mediates various NHEJ-dependent processes including immunoglobulin class-switch recombination, and fusion of unprotected telomeres.
Subunit / interactions. Component of the shieldin complex, consisting of SHLD1, SHLD2, SHLD3 and MAD2L2/REV7. Within the complex, SHLD2 forms a scaffold which interacts with a SHLD3-MAD2L2 subcomplex via its N-terminus, and with SHLD1 via its C-terminus. Interacts with ASTE1.
Subcellular location. Chromosome.
Miscellaneous. In BRCA1-deficient cells, function of the shieldin complex is necessary for sensitivity to the PARP inhibitor olaparib.
RefSeq proteins (1): NP_001352270* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR039996 | Shieldin_RINN1 | Family |
UniProt features (10 total): strand 3, region of interest 2, helix 2, chain 1, compositionally biased region 1, mutagenesis site 1
Structure
Experimental structures (PDB)
9 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 6M7B | X-RAY DIFFRACTION | 1.77 |
| 6M7A | X-RAY DIFFRACTION | 1.9 |
| 6VE5 | X-RAY DIFFRACTION | 2 |
| 6K07 | X-RAY DIFFRACTION | 2.24 |
| 6K08 | X-RAY DIFFRACTION | 2.31 |
| 6WW9 | X-RAY DIFFRACTION | 2.7 |
| 6KTO | X-RAY DIFFRACTION | 3.45 |
| 7L9P | ELECTRON MICROSCOPY | 3.6 |
| 6WWA | X-RAY DIFFRACTION | 3.8 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6ZNX1-F1 | 78.73 | 0.46 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Mutagenesis-validated functional residues (1):
| Position | Phenotype |
|---|---|
| 53–58 | fails to interact with mad2l2. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 99 (showing top):
GOBP_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR, GOBP_REGULATION_OF_CELL_ACTIVATION, GOBP_CHROMOSOME_ORGANIZATION, GOBP_REGULATION_OF_DNA_RECOMBINATION, GOBP_POSITIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE, GOBP_B_CELL_ACTIVATION, GOBP_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE, GOBP_NEGATIVE_REGULATION_OF_DNA_REPAIR, GOBP_NEGATIVE_REGULATION_OF_DNA_RECOMBINATION, GOBP_TELOMERE_ORGANIZATION, GOBP_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION, GOBP_POSITIVE_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY, GOBP_REGULATION_OF_DNA_REPAIR, GOBP_LEUKOCYTE_MEDIATED_IMMUNITY, GOBP_B_CELL_MEDIATED_IMMUNITY
GO Biological Process (8): somatic diversification of immunoglobulins involved in immune response (GO:0002208), DNA repair (GO:0006281), telomere maintenance in response to DNA damage (GO:0043247), positive regulation of isotype switching (GO:0045830), negative regulation of double-strand break repair via homologous recombination (GO:2000042), positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034), DNA damage response (GO:0006974), regulation of double-strand break repair via homologous recombination (GO:0010569)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (5): chromatin (GO:0000785), nucleoplasm (GO:0005654), chromosome (GO:0005694), nucleolus (GO:0005730), site of double-strand break (GO:0035861)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| DNA damage response | 2 |
| double-strand break repair via homologous recombination | 2 |
| cellular anatomical structure | 2 |
| nuclear lumen | 2 |
| intracellular membraneless organelle | 2 |
| immunoglobulin production involved in immunoglobulin-mediated immune response | 1 |
| somatic diversification of immunoglobulins | 1 |
| DNA metabolic process | 1 |
| telomere maintenance | 1 |
| positive regulation of immunoglobulin production | 1 |
| positive regulation of immunoglobulin mediated immune response | 1 |
| isotype switching | 1 |
| regulation of isotype switching | 1 |
| positive regulation of DNA recombination | 1 |
| positive regulation of B cell activation | 1 |
| positive regulation of developmental process | 1 |
| regulation of double-strand break repair via homologous recombination | 1 |
| negative regulation of DNA recombination | 1 |
| negative regulation of double-strand break repair | 1 |
| double-strand break repair via nonhomologous end joining | 1 |
| positive regulation of double-strand break repair | 1 |
| regulation of double-strand break repair via nonhomologous end joining | 1 |
| cellular response to stress | 1 |
| regulation of DNA recombination | 1 |
| regulation of double-strand break repair | 1 |
| binding | 1 |
| chromosome | 1 |
| site of DNA damage | 1 |
Protein interactions and networks
STRING
126 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SHLD3 | SHLD2 | Q86V20 | 995 |
| SHLD3 | SHLD1 | Q8IYI0 | 994 |
| SHLD3 | MAD2L2 | Q9UI95 | 981 |
| SHLD3 | C20orf96 | Q9NUD7 | 648 |
| SHLD3 | KIZ | Q2M2Z5 | 558 |
| SHLD3 | RIF1 | Q5UIP0 | 519 |
| SHLD3 | TP53BP1 | Q12888 | 506 |
| SHLD3 | USP28 | Q96RU2 | 476 |
| SHLD3 | PAXIP1 | Q6ZW49 | 474 |
| SHLD3 | TEN1 | Q86WV5 | 455 |
| SHLD3 | TRAPPC13 | A5PLN9 | 434 |
| SHLD3 | CTC1 | Q2NKJ3 | 393 |
| SHLD3 | BRCA1 | P38398 | 345 |
| SHLD3 | RBBP8 | Q99708 | 341 |
| SHLD3 | RBMY1D | P0C7P1 | 300 |
IntAct
14 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SHLD3 | MAD2L2 | psi-mi:“MI:0915”(physical association) | 0.650 |
| SHLD3 | MAD2L2 | psi-mi:“MI:0407”(direct interaction) | 0.650 |
| SHLD3 | MAD2L2 | psi-mi:“MI:0403”(colocalization) | 0.650 |
| SHLD3 | TP53BP1 | psi-mi:“MI:0403”(colocalization) | 0.380 |
| MAD2L2 | psi-mi:“MI:0914”(association) | 0.350 | |
| SHLD3 | psi-mi:“MI:0914”(association) | 0.350 | |
| SHLD2 | SHLD3 | psi-mi:“MI:0914”(association) | 0.350 |
| SHLD1 | SHLD3 | psi-mi:“MI:0914”(association) | 0.350 |
| SHLD3 | SHLD2 | psi-mi:“MI:0914”(association) | 0.350 |
| TP53BP1 | PSMD14 | psi-mi:“MI:2364”(proximity) | 0.270 |
ESM2 similar proteins: A1A5R8, A1L0Z4, A8PJX4, D3IUT5, O00443, P03120, P04015, P26546, P27223, P33411, P36085, P36792, Q02263, Q04383, Q08119, Q08AV6, Q08AX9, Q08D12, Q0JF48, Q4R9E9, Q5RA75, Q5RAY1, Q5RFV8, Q5TB30, Q5U4T8, Q5XGF1, Q5XH29, Q5ZKI7, Q61194, Q68FF0, Q69KN0, Q6CXP4, Q6DDJ5, Q6PUR7, Q6ZNX1, Q7Y1I7, Q81021, Q8CIG0, Q8IXR9, Q8K1K4
Diamond homologs: Q6ZNX1, Q9CZV2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
3 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
336 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:65624948:TTGA:T | donor_gain | 0.9900 |
| 5:65625107:GT:G | donor_loss | 0.9800 |
| 5:65625108:T:A | donor_loss | 0.9800 |
| 5:65624912:A:AG | donor_gain | 0.9700 |
| 5:65624913:G:GG | donor_gain | 0.9700 |
| 5:65624949:TGAG:T | donor_gain | 0.9600 |
| 5:65627993:T:G | donor_gain | 0.9600 |
| 5:65625107:G:GG | donor_gain | 0.9400 |
| 5:65625064:G:GT | donor_gain | 0.9200 |
| 5:65627989:G:GG | donor_gain | 0.9200 |
| 5:65627992:A:AG | donor_gain | 0.9200 |
| 5:65624947:GT:G | donor_gain | 0.9100 |
| 5:65627988:A:AG | donor_gain | 0.9100 |
| 5:65625103:AAAGG:A | donor_loss | 0.8700 |
| 5:65628478:G:GC | acceptor_gain | 0.8600 |
| 5:65624897:GTTT:G | donor_gain | 0.8500 |
| 5:65625109:A:C | donor_loss | 0.8500 |
| 5:65624923:TTAAG:T | donor_loss | 0.8100 |
| 5:65624924:TAAG:T | donor_loss | 0.8100 |
| 5:65624925:AAG:A | donor_loss | 0.8100 |
| 5:65624926:AGG:A | donor_loss | 0.8100 |
| 5:65624927:GG:G | donor_loss | 0.8100 |
| 5:65624928:G:C | donor_loss | 0.8100 |
| 5:65624929:T:G | donor_loss | 0.8100 |
| 5:65629462:CTTTA:C | acceptor_loss | 0.8100 |
| 5:65629463:TTTA:T | acceptor_loss | 0.8100 |
| 5:65629464:TTA:T | acceptor_loss | 0.8100 |
| 5:65629465:TAGGT:T | acceptor_loss | 0.8100 |
| 5:65629466:A:AC | acceptor_loss | 0.8100 |
| 5:65629467:G:A | acceptor_loss | 0.8100 |
AlphaMissense
1641 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 5:65630092:T:A | W169R | 0.993 |
| 5:65630092:T:C | W169R | 0.993 |
| 5:65630227:T:C | F214L | 0.982 |
| 5:65630229:C:A | F214L | 0.982 |
| 5:65630229:C:G | F214L | 0.982 |
| 5:65630191:G:C | A202P | 0.978 |
| 5:65630094:G:C | W169C | 0.977 |
| 5:65630094:G:T | W169C | 0.977 |
| 5:65630093:G:C | W169S | 0.971 |
| 5:65630085:A:C | R166S | 0.969 |
| 5:65630085:A:T | R166S | 0.969 |
| 5:65630140:T:A | W185R | 0.967 |
| 5:65630140:T:C | W185R | 0.967 |
| 5:65630192:C:A | A202D | 0.967 |
| 5:65629699:T:C | F38L | 0.964 |
| 5:65629701:T:A | F38L | 0.964 |
| 5:65629701:T:G | F38L | 0.964 |
| 5:65630150:T:C | L188P | 0.964 |
| 5:65630267:T:C | L227P | 0.962 |
| 5:65629981:T:A | W132R | 0.961 |
| 5:65629981:T:C | W132R | 0.961 |
| 5:65629864:T:C | F93L | 0.958 |
| 5:65629866:T:A | F93L | 0.958 |
| 5:65629866:T:G | F93L | 0.958 |
| 5:65629708:T:A | W41R | 0.957 |
| 5:65629708:T:C | W41R | 0.957 |
| 5:65630267:T:A | L227H | 0.957 |
| 5:65630185:T:C | C200R | 0.954 |
| 5:65630219:T:A | I211K | 0.954 |
| 5:65630230:T:C | C215R | 0.951 |
dbSNP variants (sampled 300 via entrez): RS1000077933 (5:65626539 C>T), RS1000155940 (5:65626758 T>C,G), RS1000647913 (5:65631298 A>T), RS1000790050 (5:65627107 G>A,C), RS1000971189 (5:65626809 T>C), RS1001018670 (5:65631075 G>C), RS1001337131 (5:65625804 C>T), RS1002255804 (5:65624695 A>C,T), RS1002450132 (5:65630648 T>C), RS1002481130 (5:65630959 A>G), RS1002735790 (5:65624992 C>A,G,T), RS1003085761 (5:65623037 G>A), RS1003330210 (5:65623981 C>T), RS1003453608 (5:65629300 A>G), RS1004277086 (5:65623766 GT>G)
Disease associations
OMIM: gene MIM:618030 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010701_121 | Cortical surface area (MOSTest) | 6.000000e-11 |
| GCST010702_62 | Subcortical volume (MOSTest) | 6.000000e-12 |
| GCST010703_77 | Brain morphology (MOSTest) | 2.000000e-16 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004346 | neuroimaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | affects binding, increases reaction | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.